中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

89 records (took 0.027 seconds)

    NUCLEIC ACID SUPPORTED PROTEIN COMPLEMENTATION
    81.
    发明申请
    NUCLEIC ACID SUPPORTED PROTEIN COMPLEMENTATION 有权
    核酸支持蛋白质补充

    公开(公告)号：US20100297629A1

    公开(公告)日：2010-11-25

    申请号：US12638871

    申请日：2009-12-15

    Applicant: Charles R. Cantor ,  Natalia E. Broude ,  Carlos Witte-Hoffman

    Inventor： Charles R. Cantor ,  Natalia E. Broude ,  Carlos Witte-Hoffman

    IPC: C12Q1/68 ,  C07K9/00

    CPC classification number: C12Q1/6818 ,  C12Q1/6813 ,  C12Q2563/131 ,  C12Q2561/107

    Abstract: The present invention is directed to novel methods for in vitro and in vivo detection of target nucleic acid molecules, including DNA and RNA targets, as well as nucleic acid analogues. The present invention is based on protein complementation, in which two individual polypeptides are inactive. When the two inactive polypeptide fragment are brought in close proximity during hybridization to a target nucleic acid, they re-associate into an active, detectable protein.

    Abstract translation: 本发明涉及用于靶核酸分子（包括DNA和RNA靶标）以及核酸类似物的体外和体内检测的新方法。 本发明基于蛋白质互补，其中两个单独的多肽是无活性的。 当两个无活性多肽片段在与靶核酸杂交期间紧密接近时，它们重新连接成活性的可检测蛋白质。

    Method for de novo detection of sequences in nucleic acids: target sequencing by fragmentation
    82.
    发明授权
    Method for de novo detection of sequences in nucleic acids: target sequencing by fragmentation 有权
    核酸序列的从头检测方法：通过分段进行靶序列测定

    公开(公告)号：US07807375B2

    公开(公告)日：2010-10-05

    申请号：US12259376

    申请日：2008-10-28

    Applicant: Charles R Cantor ,  Fouad A Siddiqi

    Inventor： Charles R Cantor ,  Fouad A Siddiqi

    IPC: C12Q1/68

    CPC classification number: C12Q1/6872 ,  C12Q2525/101 ,  C12Q2523/107

    Abstract: The present invention provides a method for determining nucleic acid sequences of a template nucleic acid that requires no prior knowledge of the nucleic acid sequence present in the template nucleic acid. The method is based on combining information about the mass of a fragment, the mass of any one nucleotide and the combinations thereof, and the sequence specificity of a nucleotide cutter, either enzymatic or chemical cutter, to determine a sequence of a nucleic acid fragment. This method allows for de novo detection of sequences in a target nucleic acid without requiring any prior sequence information. This method is called Partial Sequencing by Fragmentation (PSBF) and it works by fragmenting a target into oligo- or polynucleotides whose masses or lengths are uniquely associated with known sequences. The identities of these sequences are determined solely by the specific fragmentation method used, and are always independent of the target. PSBF can be implemented using electrophoresis, mass spectrometry or any other method that can be used to distinguish the size of the cut nucleic acid sequence fragments.

    Abstract translation: 本发明提供了一种确定模板核酸的核酸序列的方法，其不需要模板核酸中存在的核酸序列的先验知识。 该方法基于组合关于片段的质量，任何一个核苷酸的质量及其组合的信息以及核苷酸切割剂（酶或化学切割机）的序列特异性，以确定核酸片段的序列。 该方法允许从头检测靶核酸中的序列，而不需要任何先前的序列信息。 这种方法被称为通过片段化分段测序（PSBF），它的作用是通过将目标片段分成其质量或长度与已知序列唯一相关的寡核苷酸或多核苷酸。 这些序列的身份完全由所使用的具体碎片方法确定，并且始终与目标无关。 PSBF可以使用电泳，质谱法或可用于区分切割的核酸序列片段的大小的任何其它方法来实现。

    Method for detecting and quantifying rare mutations/polymorphisms
    83.
    发明授权
    Method for detecting and quantifying rare mutations/polymorphisms 有权
    检测和定量稀有突变/多态性的方法

    公开(公告)号：US07709262B2

    公开(公告)日：2010-05-04

    申请号：US10589709

    申请日：2005-02-18

    Applicant: Charles R. Cantor ,  Chunming Ding

    Inventor： Charles R. Cantor ,  Chunming Ding

    IPC: C12Q1/68 ,  C12P19/34

    CPC classification number: C12Q1/6827 ,  C12Q2600/156 ,  C12Q2525/186 ,  C12Q2535/125 ,  C12Q2565/627 ,  C12Q2545/101

    Abstract: The present invention is directed to a method for detecting and quantifying rare mutations in a nucleic acid sample. The nucleic acid molecules under investigation can be either DNA or RNA. The rare mutation can be any type of functional or non-functional nucleic acid change or mutation, such as deletion, insertion, translocation, inversion, one or more base substitution or polymorphism. Therefore, the methods of the present invention are useful in detection of rare mutations in, for example, diagnostic, prognostic and follow-up applications, when the targets are rare known nucleic acid variants mixed in with the wildtype or the more common nucleic acid variant(s).

    Abstract translation: 本发明涉及一种用于检测和定量核酸样品中罕见突变的方法。 正在研究的核酸分子可以是DNA或RNA。 罕见突变可以是任何类型的功能或非功能性核酸变化或突变，例如缺失，插入，易位，反转，一个或多个碱基取代或多态性。 因此，当目标是罕见的已知的与野生型或更常见的核酸变体混合的核酸变体时，本发明的方法可用于检测例如诊断，预后和随访应用中的罕见突变 （s）。

    Nucleic acid supported protein complementation
    84.
    发明授权
    Nucleic acid supported protein complementation 有权
    核酸支持的蛋白质互补

    公开(公告)号：US07662554B2

    公开(公告)日：2010-02-16

    申请号：US10529122

    申请日：2003-10-09

    Applicant: Charles R. Cantor ,  Natalia E. Broude ,  Carlos Witte-Hoffmann

    Inventor： Charles R. Cantor ,  Natalia E. Broude ,  Carlos Witte-Hoffmann

    IPC: C12Q1/68 ,  G01N33/53

    CPC classification number: C12Q1/6818 ,  C12Q1/6813 ,  C12Q2563/131 ,  C12Q2561/107

    Abstract: The present invention is directed to novel methods for in vitro and in vivo detection of target nucleic acid molecules, including DNA and RNA targets, as well as nucleic acid analogues. The present invention is based on protein complementation, in which two individual polypeptides are inactive. When the two inactive polypeptide fragment are brought in close proximity during hybridization to a target nucleic acid, they re-associate into an active, detectable protein.

    Abstract translation: 本发明涉及用于靶核酸分子（包括DNA和RNA靶标）以及核酸类似物的体外和体内检测的新方法。 本发明基于蛋白质互补，其中两个单独的多肽是无活性的。 当两个无活性多肽片段在与靶核酸杂交期间紧密接近时，它们重新连接成活性的可检测蛋白质。

    Streptavidin proteins
    86.
    发明授权
    Streptavidin proteins 失效
    链霉亲和素蛋白

    公开(公告)号：US07179618B2

    公开(公告)日：2007-02-20

    申请号：US10285876

    申请日：2002-11-01

    Applicant: Takeshi Sano ,  Alexander N. Glazer ,  Charles R. Cantor

    Inventor： Takeshi Sano ,  Alexander N. Glazer ,  Charles R. Cantor

    IPC: C12N1/20 ,  C12N15/00 ,  C07K1/00 ,  C12P21/06

    CPC classification number: C07H21/04 ,  C07K14/36 ,  C07K14/825 ,  C07K2319/00 ,  C07K2319/22

    Abstract: Streptavidin-metallothionein chimeric proteins with biological recognition specificity in which the streptavidin moiety provides high affinity biotin binding and the metallothionein moiety provides a high affinity metal binding. The binding affinity of the streptavidin-metallothionein chimeric protein both for biotin and heavy metal ions allows specific incorporation into, conjugation with, or labelling of any biological material containing biotin with various heavy metal ions.

    Abstract translation: 具有生物识别特异性的链霉亲和素 - 金属硫蛋白嵌合蛋白，其中链霉亲和素部分提供高亲和力生物素结合和金属硫蛋白部分提供高亲和力的金属结合。 链霉抗生物素蛋白 - 金属硫蛋白嵌合蛋白对生物素和重金属离子的结合亲和力允许特异性掺入，缀合或标记含有生物素与各种重金属离子的任何生物材料。

    Screening assay for the detection of DNA-binding molecules
    88.
    发明授权
    Screening assay for the detection of DNA-binding molecules 失效
    检测DNA结合分子的筛选试验

    公开(公告)号：US5726014A

    公开(公告)日：1998-03-10

    申请号：US123936

    申请日：1993-09-17

    Applicant: Cynthia A. Edwards ,  Charles R. Cantor ,  Beth M. Andrews ,  Lisa M. Turin

    Inventor： Cynthia A. Edwards ,  Charles R. Cantor ,  Beth M. Andrews ,  Lisa M. Turin

    IPC: C12N15/09 ,  C07K14/035 ,  C07K14/47 ,  C12N15/10 ,  C12N15/67 ,  C12Q1/68 ,  C12Q1/70 ,  C12P19/34 ,  G01N33/566

    CPC classification number: C12Q1/6811 ,  C07K14/47 ,  C12N15/1048 ,  C12N15/67 ,  C12Q1/6883 ,  C12Q1/705

    Abstract: The present invention defines a DNA:protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

    Abstract translation: 本发明定义了一种DNA：蛋白结合测定法，用于筛选合成或生物化合物文库结合DNA测试序列的能力。 该测定法是通用的，因为可以通过将测试序列置于与定义的蛋白质结合筛选序列相邻的位置来测试任何数量的测试序列。 分子与这些测试序列的结合改变了蛋白质分子与其同源结合序列的结合特征。 当这样的分子结合测试序列时，DNA：蛋白复合物的平衡受到干扰，产生游离DNA探针浓度的变化。 阐述了许多示例性目标测试序列（SEQ ID NO：1至SEQ ID NO：600）。 本发明的测定也可用于表征任何所选DNA结合分子的优选结合序列。

    DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
    89.
    发明授权
    DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof 失效
    编码链霉亲和素的DNA，由此产生的链霉抗生物素蛋白，包括存在于链霉亲和素中的氨基酸序列的融合多肽及其用途

    公开(公告)号：US4839293A

    公开(公告)日：1989-06-13

    申请号：US833324

    申请日：1986-02-24

    Applicant: Charles R. Cantor ,  Richard Axel ,  Carlos Argarana

    Inventor： Charles R. Cantor ,  Richard Axel ,  Carlos Argarana

    IPC: C12N15/09 ,  C07K14/36 ,  C07K14/705 ,  C12N1/20 ,  C12N5/10 ,  C12P21/02 ,  C12R1/19 ,  C12R1/465 ,  C12R1/91

    CPC classification number: C07K14/36 ,  C07K14/705 ,  C07K2319/00 ,  C07K2319/22 ,  C07K2319/33 ,  Y10S930/30

    Abstract: DNA which encodes the polypeptide streptavidin has been isolated as a fragment 2 kb in length derived from a restriction endonuclease digestion of the chromosomal DNA of Streptomyces avidinii. The nucleic acid sequence of the gene and the amino acid sequence of the polypeptide have been determined. A fused gene has been prepared which comprises the streptavidin gene fused to a gene encoding the human LDL receptor. Expression of the gene fusion results in a fused streptavidin-human LDL receptor polypeptide. Methods are provided for using the fused gene to produce labeled, chemically modified proteins in vivo and to isolate a protein knowing only the nucleotide sequence of the gene encoding the protein.

    Abstract translation: 编码多肽链霉抗生物素蛋白的DNA已经被分离为长度为2kb的片段，其来源于阿维链霉菌的染色体DNA的限制性内切核酸酶消化。 已经确定了该基因的核酸序列和该多肽的氨基酸序列。 已经制备了融合基因，其包含与编码人LDL受体的基因融合的链霉亲和素基因。 基因融合的表达导致融合的链霉亲和素 - 人LDL受体多肽。 提供了使用融合基因在体内产生标记的，化学修饰的蛋白质并分离仅知道编码蛋白质的基因的核苷酸序列的蛋白质的方法。

Patent Agency Ranking